Immunohistochemically, the tumor was positive for vimentin, EMA, PgR, TTF-1, and somatostatin receptors-2, and negative for cytokeratin, Bcl-2, CD34, and S-100, with a Ki-67 index of approximately 5%. The gene discussed is MUC1; the disease is neoplasm.